Besides the possible mechanism that overexpression of CHOP in the bone microenvironment may impair the function of osteoblasts leading to osteopenia (26), CHOP may act as a dominant-negative inhibitor of C/EBP and prevent osteoblast differentiation (27). Here, CEBPA is linked to Osteopenia.